Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2019 Sep 27;5(3):e14217.
doi: 10.2196/14217.

Evaluation of the Acute Flaccid Paralysis Surveillance System in Polio-Free Jordan, 2012-2016: Retrospective Secondary Analysis

Affiliations

Evaluation of the Acute Flaccid Paralysis Surveillance System in Polio-Free Jordan, 2012-2016: Retrospective Secondary Analysis

Fatima Zerriouh et al. JMIR Public Health Surveill. .

Abstract

Background: As part of the polio-eradication strategy, the World Health Organization (WHO) has established a global acute flaccid paralysis (AFP) surveillance system. AFP surveillance has successfully helped Jordan achieve polio-free certification. However, there is a substantial risk of polio importation from neighboring countries including Syria and Iraq.

Objective: This study aimed to evaluate the AFP surveillance in Jordan and identify areas that need improvement.

Methods: This retrospective study is a secondary analysis of data that were routinely collected between 2012 and 2016 by Jordan's Expanded Program on Immunization. The WHO's minimum performance indicators were used to evaluate the AFP surveillance.

Results: Cumulatively, 328 AFP cases had been reported. Almost half (n=168, 51.3%) of the patients were aged 1-5 years, and 55.8% (n=183) were male. All cases were discarded (classified as a nonpolio case). The most common cause of AFP was Guillain-Barre Syndrome (n=115, 35.1%). The annualized nonpolio AFP rate increased from 1.4/100,000 children below 15 years of age in 2012 to 4.3 in 2016. National and subnational sensitivities were not met in 2012 and 2013. Adequacy of stool specimens and timeliness of specimens arriving at and processed in the laboratory were constantly above the minimum target. Timeliness of the investigation met the expected target but with a decreasing trend. The nonpolio enterovirus isolation rate was below the target, except in 2016.

Conclusions: The AFP surveillance system in Jordan is performing well; however, additional efforts are needed to strengthen the subnational sensitivity. The cold chain from sample collection to laboratory testing has to be maintained to ensure the reliability of stool specimens required for isolation of the nonpolio enterovirus.

Keywords: JFETP; Jordan; acute flaccid paralysis; evaluation; polio eradication; surveillance.

PubMed Disclaimer

Conflict of interest statement

Conflicts of Interest: None declared.

Figures

Figure 1
Figure 1
Percentage of polio-vaccinated acute flaccid paralysis cases in Jordan between January 2012 and December 2016.
Figure 2
Figure 2
Flow chart showing the virological classification of AFP cases reported in Jordan between 2012 and 2016.

References

    1. World Health Organization. 2000. [2019-03-31]. Global eradication of poliomyelitis by the year 2000 https://www.who.int/ihr/polioresolution4128en.pdf .
    1. Wikipedia. [2019-03-31]. Polio eradication https://en.wikipedia.org/wiki/Poliomyelitis_eradication .
    1. Wassilak S, Orenstein W. Challenges faced by the global polio eradication initiative. Expert Rev Vaccines. 2010 May;9(5):447–9. doi: 10.1586/erv.10.45. - DOI - PubMed
    1. Hamborsky J, Kroger A, Wolfe C. Centers for Disease Control and Prevention. 2015. [2017-10-01]. Epidemiology and Prevention of Vaccine-Preventable Diseases https://web.archive.org/web/20161230001534/https:/www.cdc.gov/vaccines/p....
    1. WHO World Health Organization. 2003. [2019-08-26]. Recommended standards for surveillance of selected vaccine preventable diseases: Vaccines and Biologicals https://apps.who.int/iris/bitstream/handle/10665/70149/WHO_IVB_2009_eng..... - PubMed